There's room for lots of new antibiotics. No one freaks out when they think of Medtronic and St. Jude and other companies all having pacemakers. No need for CTIX shareholders to freak out that some other company MAY have some drug trial on another antibiotic someday. It's best for all of our health to have alternatives in case someone is allergic to a drug, or some drug treats certain infections better than another.
Interesting that we haven't heard of any allergic reactions to Brilacidin so far, isn't it?
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links